Omada Health
A billion-dollar diabetes company that's previously refused to write Ozempic prescriptions is now changing its tune — right as the drugs are about to get a lot cheaper.
Omada Health
A billion-dollar diabetes company that's previously refused to write Ozempic prescriptions is now changing its tune — right as the drugs are about to get a lot cheaper.
No comments